Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 35.55
-1.45 (-3.92%)
Nov 6, 2026, 1:55 PM CST
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 7.13 billion as of November 6, 2026. It is the 19,876th most valuable company in the world and the 823rd biggest in Taiwan. Its market cap has increased by 22.51% in one year.
Market Cap
7.13B
Enterprise Value
7.05B
Revenue
19.40M
Global Rank
Country Rank
#823 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since April 28, 2022, Locus Cell's market cap has decreased from 9.88B to 7.13B, a decrease of -27.83%. That is a compound annual growth rate of -6.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 7.17B | 24.67% |
| Dec 31, 2025 | 5.75B | 44.14% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 8.87B |
| PharmaEngine | 7.99B |
| Tanvex BioPharma | 7.34B |
| Acepodia | 7.26B |
| Adimmune | 7.17B |
| Polaris Group | 6.88B |
| Savior Lifetec | 6.48B |
| AnnJi Pharmaceutical | 6.16B |